{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:26Z","timestamp":1786114946659,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrep.2026.102478","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:08:07Z","timestamp":1770710887000},"page":"102478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IGSF9 promotes immunotherapy resistance in colon cancer by orchestrating an immunosuppressive tumor microenvironment and enables combinatorial targeting strategies"],"prefix":"10.1016","volume":"45","author":[{"given":"Kangfu","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhekang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuzhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrep.2026.102478_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.6004\/jnccn.2018.0021","article-title":"NCCN guidelines insights: Colon cancer, version 2.2018","volume":"16","author":"Benson","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102478_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bbrep.2026.102478_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174528","article-title":"Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance","volume":"134","author":"Schaer","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102478_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/0008-5472.CAN-22-1837","article-title":"Hydrogen sulfide creates a favorable immune microenvironment for Colon cancer","volume":"83","author":"Yue","year":"2023","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbrep.2026.102478_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.trecan.2019.05.010","article-title":"Integrative approaches to cancer immunotherapy","volume":"5","author":"Szeto","year":"2019","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bbrep.2026.102478_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002899","article-title":"Deregulation of HLA-I in cancer and its central importance for immunotherapy","volume":"9","author":"Hazini","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.bbrep.2026.102478_bib9","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102478_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"Cheung","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbrep.2026.102478_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101067","article-title":"IGSF9 promotes tumor invasion and metastasis through GSK-3\u03b2\/\u03b2-catenin mediated EMT in lung cancer","volume":"58","author":"Luan","year":"2024","journal-title":"Neoplasia"},{"issue":"20","key":"10.1016\/j.bbrep.2026.102478_bib15","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1158\/0008-5472.CAN-22-3115","article-title":"Targeting the immunoglobulin IGSF9 enhances antitumor T-cell activity and sensitivity to Anti-PD-1 immunotherapy","volume":"83","author":"Liu","year":"2023","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102478_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in Colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbrep.2026.102478_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","article-title":"An integrated tumor, immune and microbiome atlas of colon cancer","volume":"29","author":"Roelands","year":"2023","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bbrep.2026.102478_bib18","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrep.2026.102478_bib19","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"W1","key":"10.1016\/j.bbrep.2026.102478_bib20","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bbrep.2026.102478_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bbrep.2026.102478_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, plasticity, and tumor metastasis","volume":"30","author":"Bakir","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102478_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","article-title":"Deficient mismatch repair\/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment","volume":"175","author":"Taieb","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.bbrep.2026.102478_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102478_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrep.2026.102478_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA mismatch repair in cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12967-017-1174-z","article-title":"24h-gene variation effect of combined bevacizumab\/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling","volume":"15","author":"Baty","year":"2017","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib28","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102478_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/0008-5472.CAN-22-0074","article-title":"Meta-analysis of human cancer single-cell RNA-seq datasets using the IMMUcan database","volume":"83","author":"Camps","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41416-024-02698-4","article-title":"Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer","volume":"131","author":"Jeong","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"19","key":"10.1016\/j.bbrep.2026.102478_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102050118","article-title":"Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing","volume":"118","author":"Deshmukh","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bbrep.2026.102478_bib32","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1182\/bloodadvances.2025016432","article-title":"IGSF9-targeted therapy inhibits the progression of acute myeloid leukemia","volume":"16","author":"Hui","year":"2025","journal-title":"Blood Adv"},{"issue":"24","key":"10.1016\/j.bbrep.2026.102478_bib33","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-22-3655","article-title":"Facts and hopes on RAS inhibitors and cancer immunotherapy","volume":"29","author":"Boumelha","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102478_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104846","article-title":"Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma","volume":"97","author":"Lin","year":"2023","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.bbrep.2026.102478_bib35","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","article-title":"Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification","volume":"39","author":"Leader","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbrep.2026.102478_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-022-01242-2","article-title":"Improvement of the anticancer efficacy of PD-1\/PD-L1 blockade via combination therapy and PD-L1 regulation","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2026.102478_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbrep.2026.102478_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nsb770","article-title":"Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site","volume":"9","author":"Pargellis","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"3","key":"10.1016\/j.bbrep.2026.102478_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cgh.2005.11.013","article-title":"Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Schreiber","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:33:47Z","timestamp":1785972827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S2405580826000385"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102478","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGSF9 promotes immunotherapy resistance in colon cancer by orchestrating an immunosuppressive tumor microenvironment and enables combinatorial targeting strategies","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102478"}}